Oncology Landing 2015 Content
NOVEMBER 2015
Volume 29 • Number 11
featured article
Current Standards and Novel Treatment Options for Metastatic Pancreatic Adenocarcinoma
Benjamin A. Weinberg, MD, Cinthya S. Yabar, MD, Jonathan R. Brody, PhD, and Michael J. Pishvaian, MD, PhD
This article reviews the current treatment paradigms for metastatic disease, focusing on ways to ameliorate symptoms and lengthen survival. We then summarize recent advances in our understanding of the molecular and cellular aspects of pancreatic cancer.
Read article
Related Links
About Us
Archives
Supplements
Subscribe
Advertising
Guide to Authors
Reprints / Permissions
Editors / Publishers
Contact Us
October 2015 Issue
Oncology Digital Edition
view Past Digital Editions
Editors-in-Chief:
Julie M. Vose, MD
Nancy E. Davidson, MD
Nora Janjan, MD, MPSA, MBA
William C. Wood, MD
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F267879fc15a40ec8d3ed04d8ee9c1f044b49ee89-2990x1692.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.")
